(0.27%) 5 145.25 points
(0.29%) 38 551 points
(0.38%) 17 913 points
(-0.74%) $83.23
(1.77%) $1.957
(-0.23%) $2 341.70
(1.13%) $27.56
(0.72%) $928.70
(-0.27%) $0.932
(-0.27%) $10.99
(-0.35%) $0.798
(0.65%) $92.47
Live Chart Being Loaded With Signals
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions...
Stats | |
---|---|
Šios dienos apimtis | 47 818.00 |
Vidutinė apimtis | 118 131 |
Rinkos kapitalizacija | 755.25M |
EPS | £0 ( 2024-03-04 ) |
Last Dividend | £12.50 ( 2023-03-23 ) |
Next Dividend | £0 ( N/A ) |
P/E | 102.86 |
ATR14 | £18.83 (0.86%) |
Tūris Koreliacija
Craneware PLC Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
AMGO.L | 0.957 |
INVR.L | 0.955 |
VINO.L | 0.951 |
AVO.L | 0.949 |
CRPR.L | 0.947 |
APTA.L | 0.941 |
HHV.L | 0.939 |
MCL.L | 0.938 |
WSBN.L | 0.937 |
CNS.L | 0.935 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
JPSA.L | -0.96 |
SMEU.L | -0.956 |
EDIV.L | -0.956 |
RPAB.L | -0.956 |
CLEU.L | -0.951 |
FEDF.L | -0.95 |
FREQ.L | -0.949 |
HEDF.L | -0.949 |
JGSA.L | -0.949 |
XFFE.L | -0.948 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Craneware PLC Koreliacija - Valiuta/Žaliavos
Craneware PLC Finansinės ataskaitos
Annual | 2022 |
Pajamos: | £174.02M |
Bruto pelnas: | £148.44M (85.30 %) |
EPS: | £0.260 |
FY | 2022 |
Pajamos: | £174.02M |
Bruto pelnas: | £148.44M (85.30 %) |
EPS: | £0.260 |
FY | 2022 |
Pajamos: | £165.54M |
Bruto pelnas: | £142.37M (86.00 %) |
EPS: | £0.270 |
FY | 2021 |
Pajamos: | £75.58M |
Bruto pelnas: | £70.21M (92.89 %) |
EPS: | £0.482 |
Financial Reports:
No articles found.
Craneware PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£15.50 (N/A) |
£12.50 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £3.10 | 2008-11-05 |
Last Dividend | £12.50 | 2023-03-23 |
Next Dividend | £0 | N/A |
Payout Date | 2023-04-14 | |
Next Payout Date | N/A | |
# dividends | 31 | -- |
Total Paid Out | £254.10 | -- |
Avg. Dividend % Per Year | 0.66% | -- |
Score | 4.07 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.34 | |
Div. Directional Score | 8.32 | -- |
Year | Amount | Yield |
---|---|---|
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £24.00 | 1.31% |
2019 | £26.00 | 1.03% |
2020 | £26.50 | 1.11% |
2021 | £27.50 | 1.26% |
2022 | £28.00 | 1.16% |
2023 | £12.50 | 0.68% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RTC.L | Dividend Royal | 2023-08-03 | Annually | 27 | 157.11% | |
HINT.L | Dividend King | 2023-07-27 | Quarterly | 14 | 2.44% | |
BAG.L | Dividend Knight | 2023-05-11 | Annually | 32 | 1.26% | |
VMUK.L | Dividend Junior | 2023-05-18 | Annually | 7 | 1.91% | |
MSLH.L | Dividend Knight | 2023-10-19 | Annually | 33 | 1.56% | |
DOCS.L | Dividend Knight | 2023-06-08 | Semi-Annually | 3 | 1.23% | |
SIGC.L | Dividend Junior | 2023-09-14 | Semi-Annually | 3 | 0.82% | |
IMI.L | Dividend King | 2023-08-10 | Semi-Annually | 32 | 1.40% | |
BOY.L | Dividend King | 2023-10-05 | Semi-Annually | 32 | 1.77% | |
ORIT.L | Dividend Knight | 2023-08-17 | Quarterly | 5 | 2.77% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0515 | 1.500 | 8.97 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0278 | 1.200 | 9.07 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0623 | 1.500 | -0.419 | -0.628 | [0.1 - 1] |
payoutRatioTTM | 1.202 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 0.777 | 0.800 | -1.113 | -0.890 | [1 - 3] |
quickRatioTTM | 0.698 | 0.800 | -0.598 | -0.478 | [0.8 - 2.5] |
cashRatioTTM | 0.416 | 1.500 | 8.80 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.106 | -1.500 | 8.23 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 7.42 | 1.000 | 8.36 | 8.36 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.27 | 2.00 | 7.91 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.24 | 2.00 | 6.88 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.188 | -1.500 | 9.25 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.854 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.109 | 1.000 | 9.82 | 9.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.63 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.540 | 0.800 | 9.74 | 7.79 | [0.5 - 2] |
Total Score | 12.30 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 59.81 | 1.000 | 4.06 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0623 | 2.50 | -0.269 | -0.628 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.24 | 2.00 | 7.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.075 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.27 | 2.00 | 7.91 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.202 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -109.42 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.716 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 4.34 |
Craneware PLC
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.